Design, synthesis and antimalarial activity of benzene and isoquinoline sulfonamide derivatives

Bioorganic and Medicinal Chemistry Letters

Volumn 18, Issue 2, 2008, Pages 776-781

  Kumar Parai, Maloy ^a   Panda, Gautam ^a   Srivastava, Kumkum ^a   Kumar Puri, Sunil ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Antimalarial activity; Benzene and isoquinoline sulfonamides

Indexed keywords

BENZENE DERIVATIVE; ISOQUINOLINE DERIVATIVE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; SULFONAMIDE;

ANTIMALARIAL ACTIVITY; ARTICLE; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; MALARIA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLASMODIUM FALCIPARUM;

ANIMALS; ANTIMALARIALS; BENZENE; DRUG DESIGN; ISOQUINOLINES; PLASMODIUM FALCIPARUM; SULFONAMIDES;

PLASMODIUM FALCIPARUM;

EID: 38149023385     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2007.11.038     Document Type: Article

References (26)

1. WHO World Health Report: Changing History; World Health Organisation: Geneva, 2004.
2. Breman J.G., Egan A., and Keusch G.T. Am. J. Trop. Med. Hyg. 64 (2001) 4
3. White N.J. J. Clin. Invest. 113 (2004) 1084
4. Fidock D.A., Rosenthal P.J., Croft S.L., Brun R., and Nwaka S. Nat. Rev. Drug Disc. 3 (2004) 509
5. Campbel P. Nat. Insight 415 (2002) 6872
6. Anand, N. In Burger's Medicinal Chemistry and Drug Discovery. In Therapeutic Agents, 5th ed.; Wolff, M. E., Ed.; J. Wiley & Sons: New York, 1996; Vol. 2, p 527.
7. Bouissane L., El Kazzouli S., Le'once S., Pfeiffer B., Rakib E.M., and Khouili M. Bioorg. Med. Chem. 14 (2006) 1078
8. Melagraki G., Afantitis A., Sarimveis H., Igglessi- Markopoulou O., and Supuran C.T. Bioorg. Med. Chem. 14 (2006) 1108
9. Mandloi D., Joshi S., Khadikar P.V., and Khosla N. Bioorg. Med. Chem. Lett. 17 (2005) 15
10. Vullo D., Steffansen B., Brodin B., Supuran C.T., Scozzafava A., and Nielsen C.U. Bioorg. Med. Chem. 14 (2006) 2418
11. Sherif A., and Rostom F. Bioorg. Med. Chem. 14 (2006) 6475
12. Santos M.A., Marques S.M., Tuccinardi T., Carelli P., Panelli L., and Rossello A. Bioorg. Med. Chem. 14 (2006) 7539
13. Joshi S., Khosla N., and Tiwari P. Bioorg. Med. Chem. 12 (2004) 571
14. Örtqvist, P.; Peterson, S. D.; A° kerblom, E.; Gossas, T.; Sabnis, Y. A.; Fransson, R.; Lindeberg, G.; Danielson, U. H.; Karle'n, A.; Sandström, A. Bioorg. Med. Chem. 2007, 15, 1448.
15. Johann L., Pegraro S., Dormeyer M., Michael L., Aschenbrenner A., and Karmer B. Bioorg. Med. Chem. Lett. 14 (2004) 1979
16. Krungkrai J., Scozzafava A., Reungprapavut S., Krungkrai S.R., Rattanajak R., Kamchonwongpaisan S., and Supuran C.T. Bioorg. Med. Chem. 13 (2005) 483
17. Krungkrai S.R., Suraveratum N., Rochanakij S., and Krungkrai J. Int. J. Parasitol. 31 (2001) 661
18. Reungprapavut S., Krungkrai S.R., and Krungkrai J. J. Enzyme Inhib. Med. Chem. 19 (2004) 249
19. Domínguez J.N., León C., Rodrigues J., de Domínguez N.G., Gut J., and Rosenthal P.J. Il Farmaco 60 (2005) 307
20. Supuran C.T., and Scozzafava A. Bioorg. Med. Chem. 15 (2007) 4336
21. Krungkrai J., Krungkrai S.R., and Supuran C.T. Curr. Top. Med. Chem. 7 (2007) 909
22. Woodard C.L., Li Z., Kathcart A.K., Terrell J., Gerena L., Lopez-Sanchez M., Kyle D.E., Bhattacharjee A.K., Nichols D.A., Ellis W., Prigge S.T., Geyer J.A., and Waters N.C. J. Med. Chem. 46 (2003) 3877
23. Rieckmann K.H., Sax L.J., Campbell G.H., and Ema J.E. Lancet 311 (1978) 22
24. Trager W., and Jensen J.B. Science 193 (1979) 673
25. Lambros C., and Vanderberg Jr. J.P. Parasitology 65 (1979) 418
26. 20 For carrying out the assay, an initial ring-stage parasitaemia of ≈1% at 3% haematocrit in total volume of 200 μL of RPMI-1640 medium was uniformly maintained. The test compound in 20 μL volume at required concentration (ranging between 1.0 and 10 μg/mL) in duplicate wells was incubated with parasitized cell preparation at 37 °C in candle jar. After 36-40 h of incubation, the blood smears from each well were prepared and stained with Giemsa stain. The slides were microscopically observed to record maturation of ring-stage parasites into trophozoites and schizonts in the presence of different concentrations of compounds. The test concentration, which inhibits the complete maturation into schizonts, was recorded as the minimum inhibitory concentration (MIC). Pyrimethamine was used as the standard reference drug. Activity of all the tested compounds is given in Table 1.